Clinical Trial Update: Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of an immunostimulatory oncolytic adenovirus has completed with posted results across pancreatic adenocarcinoma, ovarian cancer, biliary tract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• Immunostimulatory oncolytic adenovirus

Snippet

Sponsor: Lokon Pharma AB | Conditions: Pancreatic Adenocarcinoma, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-19